Stay updated on Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.
Latest updates to the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check9 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoNo Change Detected
- Check38 days agoChange DetectedThe study 'Venetoclax in Combination with 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy (VENAZA-5S)' has been updated to a new version (v2.13.3) on 2024-12-09, replacing the previous version (v2.13.2) from 2023-08-08.SummaryDifference2%
- Check45 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check60 days agoChange DetectedNo new additions were noted, but a significant section of content related to data download options and study details has been removed.SummaryDifference14%
- Check74 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and a comprehensive selection of data fields for studies.SummaryDifference16%
Stay in the know with updates to Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.